Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
565-04-015 ISMRM Abstract

Development and validation of a multiparametric MRI–based radiomic model to distinguish benign from malignant sinonasal tumor

Primary: Neuro - Head & Neck/ENT
Secondary: Neuro - Tumors
565-04-015 · Neuroradiomics · Wednesday, 13 May, 2:35 PM–3:30 PM · Digital Posters Row F
Keywords: Radiomics Magnetic resonance imaging Sinonasal Region Neoplasm Differential Diagnosis
Accepted
Chaofan Sui 1, Guodan Wei1, Hangzhi Liu1, Xiaoxia Qu1, Xinyan Wang1, Junfang Xian1
1Beijing Tongren Hospital, Beijing, China
Presenting Author: Chaofan Sui

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. Jun 2012;34(6):877-85. doi:10.1002/hed.21830 [doi]
2. Chatelet F, Simon F, Bedarida V, et al. Surgical Management of Sinonasal Cancers: A Comprehensive Review. Cancers (Basel). Aug 8 2021;13(16)doi:10.3390/cancers13163995 [doi]
3. Resto VA, Deschler DG. Sinonasal malignancies. Otolaryngol Clin North Am. Apr 2004;37(2):473-87. doi:10.1016/s0030-6665(03)00159-2 [doi]
4. Thoeny HC, De Keyzer F, King AD. Diffusion-weighted MR imaging in the head and neck. Radiology. Apr 2012;263(1):19-32. doi:10.1148/radiol.11101821 [doi]
5. Xian J, Zhang Z, Wang Z, et al. Value of MR imaging in the differentiation of benign and malignant orbital tumors in adults. Eur Radiol. Jul 2010;20(7):1692-702. doi:10.1007/s00330-009-1711-0 [doi]
6. Sinkus R, Van Beers BE, Vilgrain V, DeSouza N, Waterton JC. Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development. European Journal of Cancer. 2012/03/01/ 2012;48(4):425-431. doi:https://doi.org/10.1016/j.ejca.2011.11.034 [doi]
7. Liu Z, Wang S, Dong D, et al. The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics. 2019;9(5):1303-1322. doi:10.7150/thno.30309 [doi]
8. van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B. Radiomics in medical imaging-"how-to" guide and critical reflection. Insights Imaging. Aug 12 2020;11(1):91. doi:10.1186/s13244-020-00887-2 [doi]
9. Peng Z, Wang Y, Wang Y, et al. Application of radiomics and machine learning in head and neck cancers. Int J Biol Sci. 2021;17(2):475-486. doi:10.7150/ijbs.55716 [doi]
10. Bi S, Li J, Wang T, et al. Multi-parametric MRI-based radiomics signature for preoperative prediction of Ki-67 proliferation status in sinonasal malignancies: a two-centre study. Eur Radiol. Oct 2022;32(10):6933-6942. doi:10.1007/s00330-022-08780-w [doi]
11. Wang T, Hao J, Gao A, et al. An MRI-Based Radiomics Nomogram to Assess Recurrence Risk in Sinonasal Malignant Tumors. J Magn Reson Imaging. Aug 2023;58(2):520-531. doi:10.1002/jmri.28548 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/565-04-015